KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
AcquisitionsCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Acquisitions & DivestmentsChange in CashChange in IntangiblesChange in InventoryChange in ReceivablesDeferred TaxesDepreciation & Amortization (CF)Exchange Rate EffectFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther Working Capital ChangesOther financing activitiesShare-based CompensationShares IssuedShort-Term Debt issuances
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Idexx Laboratories (IDXX) Cash from Operations (2016 - 2025)

Idexx Laboratories has reported Cash from Operations over the past 17 years, most recently at 355760000.0 for Q4 2025.

  • Quarterly results put Cash from Operations at 355760000.0 for Q4 2025, up 35.77% from a year ago — trailing twelve months through Dec 2025 was 1181805000.0 (up 27.21% YoY), and the annual figure for FY2025 was 1181805000.0, up 27.21%.
  • Cash from Operations for Q4 2025 was 355760000.0 at Idexx Laboratories, down from 402340000.0 in the prior quarter.
  • Over the last five years, Cash from Operations for IDXX hit a ceiling of 402340000.0 in Q3 2025 and a floor of 65850000.0 in Q2 2022.
  • Median Cash from Operations over the past 5 years was 205139000.0 (2021), compared with a mean of 215792300.0.
  • Biggest five-year swings in Cash from Operations: soared 346.42% in 2021 and later plummeted 71.85% in 2022.
  • Idexx Laboratories' Cash from Operations stood at 209964000.0 in 2021, then fell by 17.4% to 173428000.0 in 2022, then surged by 44.07% to 249851000.0 in 2023, then increased by 4.87% to 262025000.0 in 2024, then skyrocketed by 35.77% to 355760000.0 in 2025.
  • The last three reported values for Cash from Operations were 355760000.0 (Q4 2025), 402340000.0 (Q3 2025), and 185743000.0 (Q2 2025) per Business Quant data.